Immune profiling of BRCA-mutated breast cancers.

J. Force,S. Abbott,G. Broadwater,Ilona Stashko,K. Westbrook,G. Kimmick,Sarah Sammons,T. Hyslop,H. Brauer,Afshin Mashadi-Hossein,J. Plichta,E. Hwang,N. Kauff,K. Weinhold,S. Nair,E. Castellar,P. Marcom

Published 2018 in Journal of Clinical Oncology

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2018
Venue
Journal of Clinical Oncology
Publication date
2018-06-01
Fields of study
Biology, Medicine
Identifiers
DOI 10.1200/JCO.2018.36.15_SUPPL.585
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

No references are available for this paper.

CITED BY

Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8+ TILs based on BRCA1/2 mutation status in epithelial ovarian cancers
2024cites this paper
The differential effect of the immune system in breast cancer
2023cites this paper
A new paradox for pCR in BRCA mutation carriers
2019cites this paper
Checkpoint Blockade Strategies in the Treatment of Breast Cancer: Where We Are and Where We Are Heading
2019cites this paper